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PPHO’s Work
PPHO monitors human prion diseases in the US and coordinates programs related to these and other selected neurological 
diseases and illnesses of unknown causes such as Nodding syndrome and Kawasaki syndrome. PPHO conducts 
epidemiological research and provides expert consultation on prion diseases and Kawasaki syndrome.  Its statisticians 
provide consultation on a variety of studies related to high-consequence pathogens. 
 • Why we care:  Prion diseases, which can occur in humans and animals, are relatively rare but always fatal. Surveillance 
and research are essential to define how prion diseases spread and to identify opportunities for preventing and 
controlling these diseases.
 • Prions are abnormal protein particles that are infectious. When they multiply, they damage different parts of 
the brain.  Prions are believed to be the cause of a class of diseases referred to as prion diseases or transmissible 
spongiform encephalopathies (TSEs).
 • Kawasaki syndrome is an acute febrile illness of unknown etiology that primarily affects children younger than  
5 years of age. It is the leading cause of acquired heart disease in children in the US.
Human Prion Diseases
 • Creutzfeldt-Jakob disease (CJD, three types:  
sporadic, familial, iatrogenic)
 • Variant Creutzfeldt-Jakob disease (vCJD) 
 • Gerstmann-Straussler-Scheinker syndrome (GSS)
 • Fatal familial insomnia (FFI)
 • Variably Protease Sensitive Prionopathy (VPSPr)
 • Kuru 
 • Animal Prion Diseases
 • Bovine spongiform encephalopathy (BSE)
 • Chronic wasting disease (CWD)
 • Scrapie
 • Transmissible mink encephalopathy
 • Feline spongiform encephalopathy
 • Ungulate spongiform encephalopathy
Surveillance:
To detect and monitor the occurrence and type of prion diseases in the US, including new forms of emerging human prion 
diseases, PPHO: 
 • Supports the National Prion Disease Pathology Surveillance Center (NPDPSC), which serves to confirm clinically 
diagnosed and suspected cases of prion disease.  
 • Works with state and local health departments to investigate patients of interest, including prion disease patients 
younger than 55 years of age and those with a suspected prion exposure.
 • Monitors prion diseases among recipients of potentially contaminated pituitary-derived human growth hormone 
or blood from a donor known to have developed a non-vCJD prion disease; these are known or potential sources 
respectively of prion transmission. 
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 • Investigates new or emerging prion diseases, such as VCJD, linked to consumption of products from cows with 
bovine spongiform encephalopathy (BSE, or “mad cow” disease).
Research:
PPHO statisticians analyze data related to prion and other neurological 
diseases. To conduct these analyses, PPHO:   
 • Collaborates on research on potential links between vaccines 
and neurological disorders, including an ongoing research on 
the potential link between childhood vaccines and Kawasaki 
syndrome, and between influenza vaccines and  a neurological 
disorder, Guillain-Barré syndrome. 
 • Provides bioinformatics and statistical consultations, particularly 
on the use of large administrative datasets on causes of deaths 
and hospitalizations in the US. 
Expert Consultation:
PPHO provides consultations and support to patients’ families and physicians, infection control specialists, and other 
partners in responding to outbreaks and infectious diseases with neurological manifestations worldwide. To provide this 
support, PPHO:
 • Analyzes large data sets such as national death and hospitalization records to gather information on  
infectious diseases.
 • Educates families and physicians working with patients who have confirmed or suspected cases of prion disease.
 • Provides expert guidance on human prion disease outbreaks related to possible exposure sources.
 • Informs blood safety policies and healthcare-associated infection control policies.
PPHO in Action: Investigating Nodding 
Syndrome in Africa
PPHO co-leads an ongoing CDC investigation of nodding 
syndrome (NS), a severe neurological seizure condition of 
unknown origin affecting children in Uganda, Tanzania, and 
South Sudan. This condition impairs physical growth and 
cognitive development, rendering children almost entirely 
dependent on caregivers for life. 
Since December 2009, CDC’s multi-disciplinary teams have 
conducted studies in several African countries in an effort 
to identify the cause of NS, assess disease burden, test 
treatments, conduct laboratory analysis, and determine the 
natural history of the illness.
PPHO in Action: National Prion Disease 
Pathology Surveillance Center Confirms 
Fourth Case of Variant Creutzfeldt-
Jakob Disease (vCJD) in the US
In 2014, PPHO staff members coordinated an investigation 
in response to reports of a patient with suspected vCJD in 
Texas. The National Prion Disease Pathology Surveillance 
Center confirmed the  diagnosis of vCJD through analyses 
of the patient’s brain. The investigation indicated that 
the patient most likely contracted vCJD overseas in a 
geographic area not previously recognized as posing a risk 
for vCJD, underscoring that healthcare providers should 
not dismiss this diagnosis based solely on a patient’s 
residential and travel history. Furthermore, the investigation 
highlighted the importance of continued national 
surveillance for vCJD and the critical role that post-mortem 
brain examination plays.
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